SEARCH ARTICLES
LATEST ARTICLES
Table of Contents
2017 Month : August Volume : 6 Issue : 68 Page : 4853-4858CLINICAL PROFILE OF MATERNAL ANTIBODY-MEDIATED ABO HAEMOLYTIC DISEASE OF FOETUS AND NEWBORN.
Sajith Vilambil1, Meena Dharmadas2, Kumari Krishnakumariamma Chakrapani Usha3, Shaiji Panthiyil Shahulhameed4, Chitra James5, Anjaly Padmavilas Sasikala6, Soonam John7, Vineeth Rajagopal8
1Assistant Professor, Department of Transfusion Medicine, Government Medical College, Thrissur, Kerala.
2Professor and HOD, Department of Transfusion Medicine, Government Medical College, Trivandrum, Kerala.
3Professor and HOD, Department of Transfusion Medicine, Sree Mookambika Institute of Medical Sciences, Kulasekharam, Kanyakumari, Tamilnadu.
4Assistant Professor, Department of Transfusion Medicine, Government Medical College, Trivandrum, Kerala.
5Assistant Professor, Department of Transfusion Medicine, Government Medical College, Kollam, Kerala.
6Senior Resident, Department of Transfusion Medicine, Government Medical College, Thrissur, Kerala.
7Assistant Professor, Department of Transfusion Medicine, Government Medical College, Trivandrum, Kerala.
8Assistant Professor, Department of Family Medicine, Government Medical College, Calicut, Kerala.
References :
Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Paediatric Child Health 2005;41(9-10):504-7.
CrossRef | Google Scholar | PubMedDufour DR, Monoghan WP. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases. Am J Clin Pathol 1980;73(3):369-73.
Google Scholar | PubMedGreer JP, Foerster J, Rodgers GM, et al. Wintrobe’s clinical hematology. 12th edn. Lippincott Williams & Wilkins 2009:P 982.
Hadley AG, Wilkes A, Goodrick J, et al. The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. BJOG: An International Journal of Obstetrics & Gynaecology 1998;105(2):231-4.
CrossRef | Google Scholar |Greer JP, Foerster J, Rodgers GM, et al. Wintrobe’s clinical hematology. 12th edn. Lippincott Williams & Wilkins 2009:P 992.
Klein H, Anstee D. Mollison’s blood transfusion in clinical medicine. 11th edn. Blackwell Publishing Ltd 2005:P 530.
Chan-Shu SY, Blair O. ABO hemolytic disease of the newborn. Am J Clin Pathol 1979;71(6):677-9.
PubMedProvisional population totals India, Kerala state and districts. Government of India 2011.
Gilja BK, Shah VP. Hydrops fetalis due to ABO incompatibility. Clin Pediatr 1988;27(4):210-2.
CrossRef | Google Scholar | PubMedValentine GH. ABO incompatibility and haemolytic disease of the newborn. Arch Dis Child 1958;33(169):185-90.
PubMedSherer DM, Abramowicz JS, Ryan RM, et al. Severe fetal hydrops resulting from ABO incompatibility. Obstet Gynecol 1991;78(5 Pt 2):897-9.
Google Scholar | PubMedSchellong G. Über den einfluss mütterlicher antikörper des ABO-systems auf reticulocyten-zahl und serumbilirubin bei frühgeborenen. Commun 10th Congr Int Soc Blood Transfus, Stockholm 1964.
Levine DH, Meyer HBP. Newborn screening for ABO hemolytic disease. SAGE Journals 1985;24(7).
CrossRef | Google Scholar |Whyte J, Graham H. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests. Acta Paediatr Scand 1981;70(2):217-22.
Google Scholar | PubMedMollison PL, Cutbush M. Haemolytic disease of the newborn due to anti-A antibodies. Lancet 1949b;ii:173.
Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007;92(2):F83-8.
CrossRef | PubMedMollison PL, Cutbush M. A method of measuring the severity of a series of cases of hemolytic disease of the newborn. Blood 1951;6:777-88.
CrossRef | Google Scholar |Crawford H, Cutbush M, Mollison PL. Hemolytic disease of the newborn due to anti-A. Blood 1953;8(7):620-39.
CrossRef | Google Scholar | PubMedLevine P, Vogel P, Rosenfield RE. Hemolytic disease of the newborn. Adv Pediatr 1953;6:97-156.
PubMedGrumbach A, Gasser C. ABO-inkompatibilitäten und morbus haemolyticus neonatorum. Helv Paediatr Acta 1948;3(6):447-74.
PubMedComos BJ, Crusafont RA, Pujol NA, et al. Value of the coombs test in ABO incompatibility. J An Esp Pediatr 1991;35(4):248-50.
Google Scholar | PubMedOsborn LM, Lenarsky C, Oakes RC, et al. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics 1984;74(3):371-4.
CrossRef | Google Scholar |Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004;28(5):326-33.
Google Scholar | PubMedKaplan E, Herz F, Scheye E, et al. Phototherapy in ABO hemolytic disease of the newborn infant. The Journal of Pediatrics 1971;79(6):911-4.
CrossRef | Google Scholar |Rosenfield RE. A-B hemolytic disease of the newborn. Analysis of 1480 cord blood specimens, with special reference to the direct antiglobulin test and to the group O mother. Blood 1955;10:17-28.
Google Scholar |Ames AC, Lloyd RS. A scheme for the ante-natal prediction of ABO haemolytic disease of the newborn. Vox Sang 1964;9:712-22.
CrossRef | Google Scholar | PubMedKlein H, Anstee D. Mollison’s blood transfusion in clinical medicine. 11th edn. Blackwell Publishing Ltd 2005:P 534.
Falterman CG, Richardson CJ. Transfusion reaction due to unrecognized ABO hemolytic disease of the newborn infant. J Pediatr 1980;97(5):812-4.
Google Scholar | PubMedMiqdad AM, Abdelbasit OB, Shaheed MM, et al. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 2004;16(3):163-6.
CrossRef | Google Scholar | PubMedLakatos L, Csathy L, Nemes E. Bloodless treatment of a Jehovah’s witness infant with ABO hemolytic disease. J Perinatol 1999;19(7):530–2.
Google Scholar | PubMedRomano EL, Soyano A, Montano RF, et al. Treatment of ABO hemolytic disease with synthetic blood group trisaccharides. Vox Sang 1994;66(3):194-9.
CrossRef | Google Scholar | PubMed